<SEC-DOCUMENT>0001493152-23-003398.txt : 20230822
<SEC-HEADER>0001493152-23-003398.hdr.sgml : 20230822
<ACCEPTANCE-DATETIME>20230202142455
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001493152-23-003398
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230202

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MDB Capital Holdings, LLC
		CENTRAL INDEX KEY:			0001934642
		STANDARD INDUSTRIAL CLASSIFICATION:	FINANCE SERVICES [6199]
		IRS NUMBER:				874366624
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		4209 MEADOWDALE LN
		CITY:			DALLAS
		STATE:			TX
		ZIP:			95229
		BUSINESS PHONE:		310-526-5000

	MAIL ADDRESS:	
		STREET 1:		4209 MEADOWDALE LN
		CITY:			DALLAS
		STATE:			TX
		ZIP:			95229
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps; text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps; text-transform: none">GOLENBOCK
EISEMAN ASSOR BELL &amp; PESKOE LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps; text-transform: none">711
THIRD AVENUE &ndash; 17<SUP>TH</SUP> FLOOR</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps; text-transform: none">NEW
YORK, NEW YORK 10017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps; text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps; text-transform: none">Direct
Dial No.: (212) 907-7349</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps; text-transform: none">Direct
Fax No.: (212) 754-0330</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps; text-transform: none">Email
Address: AHudders@golenbock.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps; text-transform: none">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    2,</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2023</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
States Securities and Exchange Commission</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Division
of Corporation Finance &ndash; Office of Finance</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Washington,
DC 20549</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Tonya Aldave</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Susan Block</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    William Schroeder</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Amit Pande</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Re:</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MDB
                                            Capital Holdings, LLC</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration
    statement on Form S-1</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Original
    file date: November 10, 2022</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment
    file date: December 28, 2022</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    No. 333-268318</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Sirs and Mesdames:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference
is made to the letter of the staff (the &ldquo;Staff&rdquo;) of the Securities and Exchange Commission (the &ldquo;Commission&rdquo;),
dated January 20, 2023, commenting on Amendment No. 1 to the registration statement on Form S-1 (&ldquo;Form S-1&rdquo;) of MDB Capital
Holdings, LLC (the &ldquo;Company&rdquo;), filed on December 28, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
am responding on behalf of the Company as its counsel, to the comment letter. The response format sets forth the Staff comment followed
by the response thereto of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
and Exchange Commission</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
2,</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
2</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Amendment
No. 1 to Registration Statement on Form S-1 </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>General</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            note your revised disclosure that you are offering securities on a no minimum basis. Please
                                            revise the use of proceeds and dilution sections to detail the use of proceeds and dilution
                                            if 25%, 50%, 75% and 100% of the securities are sold, or advise.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has added disclosure in each of the Sections &ldquo;Use of Proceeds&rdquo; and &ldquo;Dilution&rdquo; to indicate the use of
proceeds and dilution per class A common share for the four above indicated amounts of proceeds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
                                            revise the summary section to disclose your multiple class share structure and explain the
                                            nature of the disparate voting rights and the risks the structure presents to investors.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
subsection &ldquo;Two Class Shareholder Structure: class B common share control&rdquo; section within the Section &ldquo;Prospectus Summary&rdquo;
has been expanded to discuss further the risks presented to investors in the class A common shares and to add to that section from elsewhere
in the prospectus the discussion about the difference in voting authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
has been stated previously in the prospectus, that the rights of the two classes of common shares are the same but for (i) the different
number of votes per share between the classes and (ii) the fact that the class B common share has a conversion right into the class A
common share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            note that after the offering completion you will be a controlled company, with two of your
                                            shareholders holding more than 50% of the voting power. Please disclose the percentage of
                                            outstanding Class B shares that shareholders must keep in order to continue to control the
                                            outcome of matters submitted to shareholders for approval.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
response to the Staff comment, the Company has inserted the following in relevant places in the prospectus to indicate when the controlled
company status would end: &ldquo;We will remain a controlled company until we have issued and outstanding 25,000,001 class A common shares,
assuming no conversions of any class B common shares..&rdquo; The Company believes, stating its response in this manner to indicate the
number of class A common shares needed for that class to be in the majority is easier to understand than disclosing it in terms of percentages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
and Exchange Commission</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
2,</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
3</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            note your response to our prior comment 25. We have referred your response to the staff of
                                            the Division of Investment Management. You may receive further comment.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
response required currently.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Prospectus
Summary </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Overview,
page 1</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            note your response to our prior comment 2 and reissue. Please revise the introductory paragraphs
                                            of your summary section to include your revenue and net losses for the most recent audited
                                            period and interim stub to provide a financial snapshot of your company and to balance the
                                            disclosure in this section.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has updated the introductory summary about the offering to include a brief statement of the revenue and net losses for the most
recent audited period and interim stub period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Alternate
Page for Security Holder Prospectus </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Selling
Security Holders, page 5</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            note the percentage of shares owned before and after the offering is based on a number as
                                            of September 30, 2022. Please update to the most recent practicable date or advise.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table has been updated to calculations as of January 31, 2023, based on the outstanding class A common shares as of December 31, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
and Exchange Commission</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
2,</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
4</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
                                            briefly describe the transactions from which the selling shareholders originally received
                                            their shares, including the exemption from registration for the original transaction and
                                            the date of the transaction.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
has been added to the description of the Section &ldquo;Selling Security Holders&rdquo; a paragraph about the private placement transaction
in which the selling security holders acquired their class A common shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Risk
Factors, page 11</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
                                            add risk factor disclosure describing the fact that your multi-class capital structure may
                                            have anti-takeover effects preventing a change in control transaction that shareholders might
                                            consider in their best interests. In addition, add risk factor disclosure describing the
                                            risks to investors that future issuances of high-vote shares may be dilutive to low-vote
                                            shareholders.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
has been added to the Section &ldquo;Risk Factors,&rdquo; subsection &ldquo;<FONT STYLE="background-color: white">Risks Related to this
Being a Public Company and Owning Our Class A Common Shares&rdquo; a risk factor indicating several aspects of the class A common shares
and class B common shares that present anti-takeover impediments and a risk factor how the board of directors of the Company may issue
additional securities that have a dilutive effect on the voting authority of the class A common shares.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>The
market, including clients and potential investors, may be skeptical, page 24</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            note your response to our prior comment 4 and your disclosure here and on page 67 that Invizyne&rsquo;s
                                            &ldquo;SimplePath systems and the resultant pipeline products are in various stages of the
                                            research and development phase, the pilot production phase and/or in pre-clinical assessment
                                            as a therapeutic.&rdquo; Please explain what you mean by &ldquo;pilot production phase,&rdquo;
                                            because it appears that Invizyne has not obtained FDA approval to begin production of any
                                            of its products. If FDA approval is not required for any of Invizyne&rsquo;s pipeline products,
                                            please revise to explain why it is not required, in the alternative, please remove references
                                            to &ldquo;pilot production.&rdquo;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
disclosure in the risk factor &ldquo;The market, including clients and potential investors, may be skeptical&hellip;&rdquo; and the disclosure
in the business section about Invizyne has been adjusted to explain what is meant by the term &ldquo;pilot production.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
and Exchange Commission</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
2,</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
5</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
this point in time, the research and development of potential products by Invizyne are in such an early stage, there is no determination
yet to be made whether or not any potential products will be of a nature that requires FDA or any other governmental approval. So to
date, no FDA approval is needed or has been sought. The potential products may remain purely at the laboratory level or be developed
such that they are not for medical or other direct human use that would need governmental approvals. Of course, if the potential products
will require government approval, then those applicable rules and regulations will be considered and followed. In the two areas of disclosure
in the prospectus, we have indicated that the research is early.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>PatentVest
is licensed to offer legal services under Arizona law, page 26</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
                                            advise and expand your risk factor disclosure, if applicable, as to whether any additional
                                            regulatory approvals are necessary for PatentVest to launch its law firm operations once
                                            it is a subsidiary of a public company. Please also include a discussion of the regulations
                                            that will materially impact the firm, under &ldquo;Regulation,&rdquo; as applicable. Please
                                            also discuss if Arizona is the only state that allows a law firm to be owned by a non-lawyer
                                            and discuss the extent this would prevent the law firm from expanding outside of Arizona.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
law license for the Arizona law firm of PatentVest has been fully and finally issued. Therefore, there is no risk factor that would be
relevant relating to any additional regulatory approvals for establishment of the Arizona law firm.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the sub-section &ldquo;Regulation&rdquo; of &ldquo;Business&rdquo; there has been added a discussion about the applicable court rules
which govern the operation of the law firm business of PatentVest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
and Exchange Commission</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
2,</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
6</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
has been added to the Section &ldquo;Business&rdquo;, in the subsection about &ldquo;PatentVest,&rdquo; a discussion that Arizona and
Colorado are the only two states that currently permit a non-lawyer ownership of a law firm. It is also indicated in the disclosure that
since the firm plans to operate only in Arizona and most of its law practice will be focused on patent prosecution, which is federally
oriented, there is no anticipated need to be able to have offices in jurisdictions other than Arizona.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Use
of Proceeds, page 34</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            note your response to our prior comment 5 and your revised disclosure that you plan to negotiate
                                            acquisition of certain technology. If any material amount of proceeds is to be used to acquire
                                            assets, otherwise than in the ordinary course of business, please describe briefly and state
                                            the cost of the assets and whether such assets are to be acquired from your affiliates or
                                            associates. Refer to Instruction 5 to Item 504 of Regulation S-K.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
this time there are no activities to acquire technologies. Therefore, there is no allocation in the use of proceeds for the expense of
any activities for acquisitions. There, however, is allocation for investigations to locate future technologies for review and due diligence
activities. There is no current plan to acquire assets from affiliates or associates, so no disclosure about affiliate acquisition has
been added to the Section &ldquo;Use of Proceeds.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operations Results of Operations, page 38</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            note that Other operating income, which appears to primarily comprise income from trading,
                                            is a significant source of your revenues in 2022. To the extent trading revenues continue
                                            to be significant please revise to separately disclose them in your statements of operations,
                                            and enhance your discussion about your trading volumes including any quantitative information
                                            to provide a reader better understanding of any material changes in trends that affect your
                                            operating results.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has updated the Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations Results of Operations
section to enhance the discussion on trading volumes and trends that affected operating results for other operating income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
and Exchange Commission</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
2,</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
7</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Broker
Dealer and Intellectual Property Service Segment (Public Ventures and PatentVest) Results of Operations for the Years Ended December
31, 2021 and 2020, page 45</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
                                            refer to comment 16. We note from your response that the realized gain on investment securities
                                            related to investments acquired through open market purchases, founders shares, or warrants
                                            from investment banking deals. We further note from your response and your disclosure on
                                            page 46 that you used ASC 320-10 to determine the amount of realized gain. Please address
                                            the following:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
    provide us detailed information by investment type, such as equity securities, debt securities, and warrants, for the investments
    sold or purchased during 2020, including acquisition price, sale price and realized gain(s) or loss.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
    that the guidance in ASC 320-10 relates to debt securities, please tell us how you accounted for your investments in securities other
    than debt securities.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
    also tell us and revise your accounting policy footnote to disclose the authoritative accounting guidance you relied upon to account
    for each of these types of securities. Please also tell us if and how you considered the guidance in ASC 940 for any of your assets
    held in your broker dealer subsidiary.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
see below for detailed information by investment type for the investments sold or purchased during 2020, including acquisition
price, sale price and realized gain(s) or loss.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="formcorresp_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company updated the financial footnotes to include disclosure of ASC 321-10 <I>Accounting for Equity Interests</I> and ASC 815-10 <I>Derivatives
and Hedging</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company used the following authoritative accounting guidance that was relied upon to account for the following types of securities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments
                                            at amortized cost ASC 320-10;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments
                                            at fair value ASC 940-320-30, ASC 321-10, and ASC 815-10;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments
                                            in equity securities that do not have a readily determinable fair value, ASC 321-10-35; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
                                            sold, not yet purchased &#8211; ASC 940-320-30, ASC 321-10, and ASC 815-10.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0 0pt 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considered the guidance in ASC 940-320-30, where a broker-dealer may buy and sell securities on its own account. The Company
accounted for broker dealer activity at fair value, changes are accounted for at fair value and recognized in earnings in accordance
with the following accounting guidance:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments
                                            held to maturity - ASC 940-320-30-1;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments
                                            available for sale - ASC 940-320-30-2;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments
                                            held to maturity being transferred to available for sale - ASC 940-320-35-1; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments
                                            available for sale being transferred to held to maturity - ASC 940-320-35-3.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0 0pt 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has considered the guidance above, and the Company believes they are following the guidance. This is disclosed in Note 2 of the
financial statements where the accounting policy addresses Investment Securities and Securities Sold Not Yet Purchased. In Note 2 the
Company disclosed the initial recognition, subsequent measurement, and the determination of realized gains and losses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
and Exchange Commission</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
2,</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
8</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Financial
Condition, page 47</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
                                            refer to comment 6 and your revised disclosures on page 47. Please revise to more clearly
                                            explain the changes in specific balance sheet line items you are referring to in the following
                                            two sentences included in the last two paragraphs on page 47:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    was primarily due to the reduction of securities sold not yet purchased in 2021.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    was primarily driven by the decrease of the value of securities and securities distributed to members during 2021.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
please also refer to SEC Release No. 33-10890 on Management&rsquo;s Discussion and Analysis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has updated the Financial Condition section of the Management Discussion and Analysis to document the decrease in liabilities
and equity from the years ended December 31, 2021 and December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Executive
Compensation, page 78</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            note your response to our prior comment 13 and that your summary compensation table includes
                                            option awards. Please include a separate table with information relating to the option awards.
                                            Refer to Item 402(p) of Regulation S-K.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has updated the Executive Compensation section to add a separate table with information relating to the option awards as prescribed
in Item 402(p) of Regulation S-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Description
of Capital, page 83</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            note your response to our prior comments 15 and 27. Please revise here and on the cover page
                                            to clarify what you mean by &ldquo;common equivalent equity&rdquo; and clarify the extent
                                            to which the common shares you are offering differ from rights typical of common equity.
                                            Please further explain what you mean by disclosure that your two classes of common equity
                                            represent your limited liability membership interests, why you have designated them as class
                                            A common shares and class B common shares, and why you refer to them as Class A common shares
                                            on the cover page and in the fee table. In that regard, please explain and clarify how the
                                            class A common shares and class B common shares represent your limited liability interests.
                                            In your response, please tell us if you are just using a different nomenclature for your
                                            limited liability interests and why you have chosen to designate the interest in this way.
                                            Please also explain to us what you mean when you tell us in your response that under Delaware
                                            law, there is no limitation on how a limited liability company might denominate their membership
                                            interests, and how that statement relates to your offering of class A common shares. Please
                                            advise us whether these LLC &ldquo;common equity equivalent&rdquo; Class A common shares
                                            you are offering will satisfy the criteria for listing common stock equivalents on Nasdaq.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term, &ldquo;common equivalent equity&rdquo; has been eliminated from the prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
and Exchange Commission</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
2,</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
9</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
help clarify that the class A common shares are securities of a limited liability company, there has been added at certain disclosure
points in the registration statement and prospectus the following language to indicate that the class A shares are representative of
limited liability interests: &ldquo;class A common shares representing limited liability interests.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
use of the term &ldquo;class A common stock&rdquo; is the nomenclature that the Company and its tax advisors used in the operating agreement.
We note that there are a number of companies that are publicly traded limited liability companies that use a similar nomenclature. These
include, GBLI Holdings, LLC, Gyrodyne, LLC, CIFC LLC, and Apollo Global Management, LLC, among others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
has been added in several places, including the cover and in the Section &ldquo;Description of Capital&rdquo; how the Company has the
ability to use and why it uses the term common shares. We wish to draw to the attention of the Staff that the corporate governance aspects
of the common shares are similar in many respect to the rights of a corporate shareholder under Delaware law for a stock corporation.
In fact, in the operating agreement for the Company, there are many sections that incorporate by reference the corporate law provisions
for shares of a Delaware corporation. There has been added disclosure in both the sub-section &ldquo;Corporate Structure&rdquo; in the
Section &ldquo;Summary&rdquo; and in the Section &ldquo;Description of Capital&rdquo; about the corporate governance provisions of the
common shares that are similar to those of a Delaware stock corporation. Also in that discussion there has been indicated a reference
and cross reference to the tax discussion which applies to the common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware
law applicable to limited liability companies does not indicate how a limited liability company might designate the nomenclature of its
securities. The Company looked at other publicly traded partnerships that were limited liability companies and used the nomenclature
of those it looked at, including those referenced above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
and Exchange Commission</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
2,</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
10</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has consulted with the listing officer at NASDAQ, and verified that using the nomenclature of &ldquo;class A common share&rdquo;
to represent an interest in a limited liability company is not an issue. If you like, you may contact Ms. Vivian Hui, Regulatory Compliance
Specialist Listing Qualifications Department, at 1-301-978-8062.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Fair
Value of Financial Instruments, page F-31</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
                                            refer to comment 19. We note from your response that realized gains of $2,178,337 during
                                            2021 related to two non-trading warrants for publicly traded stock held until their distribution
                                            to members in Q4 2021. We note that you present Gain on distributed investment securities
                                            to members&rsquo; of $2,414,093 in your results of operations. Please tell us and revise
                                            to disclose a) the reason for the difference in the two amounts, and b) how you determined
                                            the fair value of these warrants at the time of their distribution in Q4 2021.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has revised the footnote to break out the gain on distributed investment securities to members of $2,414,093 between the gain
of Level 3 warrants and the gain on the distribution of Level 1 securities and how we determined fair value of the warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*****</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
and Exchange Commission</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
2,</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
11</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company understands that its management persons are responsible for the accuracy and adequacy of their disclosures, notwithstanding any
review, comments, action or absence of action by the staff of the Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you have any questions about the foregoing, please do not hesitate to contact Andrew D. Hudders of this firm at 212-907-7349 or ahudders@golenbock.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/S/
    Golenbock Eiseman Assor Bell &amp; Peskoe LLP</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Golenbock
    Eiseman Assor Bell &amp; Peskoe LLP</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cc:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Christopher Marlett,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mo
    Hayat,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    of Entrepreneurship &amp; Operations</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>formcorresp_001.jpg
<TEXT>
begin 644 formcorresp_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #B G # 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5YWJWC^6Q^(<.FI=62Z3#/#8W
M4;L/.,TJLRLO.=J_NP>/XCZ5Z)7-7/@#PO>17:W&D022W4QGEN&&9MY8-D2?
M>7D# ! %"W#H94_Q.LX$UQCI%^?[)E$;+E TF7V[L%LHN>=S8&.:KW_Q>T33
MK_3[26VN"]U#%-)M>,^2)#A>-WS^^S.!S6T_P^\.R2WLS6USYUY@22B\E#J
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M--\.WBRRV]B(V1XI6B8R(/OY4@@DDGKWJ*X^'7AJ[:!KBUN)6CC$3%[N4F=
M<A9?F_> $G[V:-M/Z_J]P\_Z_JQ2G^)EC#=ZS"NEW\@TR$394+NG!*C*IG=M
M^8?,1C //%=+H&L1Z_H=KJ<431)<+N"%U?')'520>G4&LV;P'X?N+^[OI+:?
M[3=(49Q=2 Q@D$^7AOW>2 ?EQTK5T?1K#0-+BT[38/)M8LE5W%B23DDDY)))
M)R: +]%%% !1110 4444 %%%49]9TVUO4LY[ZWCN7QMB:0!CGIQ[T 7J***
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MV+W4_O=W;KGI76^$V(CU>W7_ %%OJ<Z0@= IPQ ^C,PJK$W.AHHHI#"BBB@
MHHHH *;Y:%P^Q=X& V.:=10 U8T085%49S@#'-+M7^Z/RI:* $VKZ#\J3RTW
M,VQ=S=3CDTZB@ P,YQS3/*CV%/+3:3DC'!I]% #0B!RX50QX+8Y-"QH@PJ*!
MZ 8IU%    , 8%-**6#%06'0XY%.HH 3:N,;1C&.G:D5$0 *JJ!T &,4ZB@!
M J@DA0">I ZTT11A @C3:#D#' -/HH :44@@J"",$$=:5555"J  .@ Z4M%
M!1110 4444 %%%% !1110 4444 %%%% ",H92K $'J#5:33;22ZM[EH%\RW+
M-$1P%+#!..F<<9]S5JB@!BQ1JA18U"'JH'!I3'&5"E%*KT!' IU% %6+3K2&
M6YE6%2]S())6;YBS !1U]  *G>&*0@O&C$?WE!I]% #1&BN7"*&/5@.33J**
M "BBB@ HHHH *@O+2"_LIK2YC$D$R%'0]P:GHH B2VA39B-2R@ ,PRWY]:<(
MHUW;44;OO8'7ZT^B@"K+I]K-<VMP\0,EJ6,/. A88)QTSC(_$U:HHH ****
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M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2,P52QS@#/
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M#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML$>2D8"8/7Y1QS3 YB2XN#XN\.S_ -HW8@N[:4-9N=B9"*=Q7&2V3WZ=JO\
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M&HHZW Y6#PG=6GB2TU*/59I8EDGEN%D2/+LX4<$)G'&.3P  *ZJBB@ HHHH
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M!GAFXO+2[ET*P:>T54@<PC]VJ_= ^G:MVB@#)T/08M$_M!UGDGGO[M[N:60
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H !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
